Celcuity CELC
NASDAQ CELC
$79.54 +2.16 (+2.78%)
As of: Sep 30, 2026 · 3:59 PM EDT

Celcuity (CELC) Other Operating Expenses (2025)

Updated

Celcuity (CELC) recorded Other Operating Expenses of -$5,000 in Q4 2025.

Analysis

Celcuity (CELC) Other Operating Expenses (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Celcuity 3.79 Bn 3.79 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -5,000.00
API Access

Celcuity Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CELC&period=max&api_key=YOUR_API_KEY